Skin & Laser Surgical Ctr-New Everett, MA - 02149

Skin & Laser Surgical Ctr-New is categorized under Hospitals in Everett, MA and active since 2010.

Skin & Laser Surgical Ctr-New was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Carolina Pinto, Office Manager at the company’s single location by writing to 153 Main St, Everett, Massachusetts MA 02149 or by phoning (617) 381-1717. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Skin & Laser Surgical Ctr-New
Contact Person: Carolina Pinto, Office Manager
Address: 153 Main St, Everett, Massachusetts 02149
Phone Number: (617) 381-1717
Website Address: skinlaseronline.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Hospitals
SIC Code: 8062
NAICS Code: 6211110
Share This Business:

Skin & Laser Surgical Ctr-New was started in 2010 to provide professional Hospitals under the SIC code 8062 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Carolina Pinto, Office Manager for inquiries that concern Skin & Laser Surgical Ctr-New by calling the company number (617) 381-1717, as your correspondence is most welcome. Additionally, the physical location of the single location of Skin & Laser Surgical Ctr-New can be found at the coordinates 42.40607,-71.06188 as well as the street address 153 Main St in Everett, Massachusetts 02149.

For its online presence, you may visit Skin & Laser Surgical Ctr-New’s website at skinlaseronline.com and engage with its social media outlets through on Twitter and on Facebook.